- Home
- SCNI vs ONFO Comparison
SCNI vs ONFO Comparison
Compare SCNI & ONFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNI
- ONFO
- Stock Information
- Founded
- SCNI 2003
- ONFO 2018
- Country
- SCNI Israel
- ONFO United States
- Employees
- SCNI N/A
- ONFO N/A
- Industry
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- ONFO Computer Software: Programming Data Processing
- Sector
- SCNI Health Care
- ONFO Technology
- Exchange
- SCNI Nasdaq
- ONFO Nasdaq
- Market Cap
- SCNI 4.6M
- ONFO 5.0M
- IPO Year
- SCNI N/A
- ONFO 2022
- Fundamental
- Price
- SCNI $1.37
- ONFO $1.17
- Analyst Decision
- SCNI
- ONFO
- Analyst Count
- SCNI 0
- ONFO 0
- Target Price
- SCNI N/A
- ONFO N/A
- AVG Volume (30 Days)
- SCNI 95.4K
- ONFO 159.1K
- Earning Date
- SCNI 11-21-2025
- ONFO 11-14-2025
- Dividend Yield
- SCNI N/A
- ONFO N/A
- EPS Growth
- SCNI N/A
- ONFO N/A
- EPS
- SCNI 0.26
- ONFO N/A
- Revenue
- SCNI $1,147,000.00
- ONFO $10,508,728.00
- Revenue This Year
- SCNI N/A
- ONFO N/A
- Revenue Next Year
- SCNI N/A
- ONFO N/A
- P/E Ratio
- SCNI $5.20
- ONFO N/A
- Revenue Growth
- SCNI 303.87
- ONFO 78.36
- 52 Week Low
- SCNI $1.20
- ONFO $0.61
- 52 Week High
- SCNI $6.18
- ONFO $1.95
- Technical
- Relative Strength Index (RSI)
- SCNI 45.19
- ONFO 51.76
- Support Level
- SCNI $1.32
- ONFO $1.09
- Resistance Level
- SCNI $1.63
- ONFO $1.17
- Average True Range (ATR)
- SCNI 0.11
- ONFO 0.09
- MACD
- SCNI 0.01
- ONFO -0.00
- Stochastic Oscillator
- SCNI 38.37
- ONFO 41.33
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.
About ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place. The company operates in two business segments: Business to Business (B2B) and Business to Consumers (B2C). The majority of its revenue is generated from the Business-to-Business (B2B) segment, which includes the results of operations of Eastern Standard, RevenueZen, DDS Rank, SEO Butler, Contentellect, DealPipe, and Onfolio LLC.